In summary, we revealed that DPP4, CTNNB1, and MET oncogenic signatures are overexpressed in THCA, and are associated with cancer progression, metastasis, resistance, poor disease-free survival, and unfavorable clinical outcomes. The gene discussed is CTNNB1; the disease is cancer.